RECRUITING

Characterization of Fetal Lung With Quantitative Ultrasound

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the study is to show if it's possible to use a special kind of ultrasound called backscatter quantitative ultrasound (bQUS) to check on a baby's lungs when the mother is 36 weeks pregnant. 12 participants will be on study for a single 30 minute ultrasound between 32 and 36 weeks of pregnancy.

Official Title

Characterization of Fetal Lung With Quantitative Ultrasound

Quick Facts

Study Start:2024-12-17
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06722365

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant females ages 18 to 45 years old with singleton pregnancy, live fetus, gestational age between 32.1 and 36.7 weeks, not in labor, scheduled for routine ultrasound growth evaluation.
  2. * Gestational age determined by the date of the last menses, and confirmed by measurement of the crown-rump-length on transabdominal ultrasound.
  1. * Subjects unable to consent.
  2. * Active Labor
  3. * Hypertensive disorders of pregnancy
  4. * Fetal growth restriction
  5. * Fetal malformations
  6. * Prescription of corticosteroids prior to ultrasound evaluation
  7. * Pre-gestation or gestational diabetes mellitus
  8. * Multiple pregnancy
  9. * Low English proficiency, needing an interpreter

Contacts and Locations

Study Contact

Sharon Blohowiak
CONTACT
(608) 417-6957
sblohowiak@wisc.edu

Principal Investigator

J. Igor Iruretagoyena, MD, MS
PRINCIPAL_INVESTIGATOR
UW School of Medicine and Public Health

Study Locations (Sites)

Meriter Hospital
Madison, Wisconsin, 53715
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • J. Igor Iruretagoyena, MD, MS, PRINCIPAL_INVESTIGATOR, UW School of Medicine and Public Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-17
Study Completion Date2025-11

Study Record Updates

Study Start Date2024-12-17
Study Completion Date2025-11

Terms related to this study

Additional Relevant MeSH Terms

  • Respiratory Complication
  • Fetal Lung Imaging